Global Chronic Renal Failure Therapeutics Market 2019-2023
- Published: Jun 2019
- Pages: 145
- SKU: IRTNTR31343
Enjoy complimentary customisation on priority with our Enterprise License!
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
The global chronic renal failure therapeutics market size will grow by USD 3.17 billion during 2019-2023. The chronic renal failure therapeutics market report provides a detailed analysis of the market by product (antihypertensive therapeutics, antianemia therapeutics, and others) and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including Amgen Inc., AstraZeneca Plc, Bayer AG, F. Hoffmann-La Roche Ltd., and Pfizer Inc.
A few of the key findings this chronic renal failure therapeutics market analysis report are summarized below
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from the chronic renal failure therapeutics market report.
Global Chronic Renal Failure Therapeutics Market Overview
The global chronic renal failure therapeutics market witnessed significant growth in both the developing and developed countries across the globe in recent years. Cardiovascular and metabolic disorders are significant risk factors for chronic renal failure. The rising prevalence of these risk factors is contributing to the significant increase in the incidence of chronic renal disease. According to the CDC, adults with chronic renal disease are having a higher risk of mortality. The majority of the demand for the treatment of this condition is from the geriatric population in the US, Europe, and Asia. This rising prevalence of chronic renal failure will subsequently augment the growth prospects of the global chronic renal failure therapeutics market during the forecast period.
Moreover, the development of novel hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitors will also fuel chronic renal failure therapeutics market growth. Oral HIF-PH inhibitors such as roxadustat and vadadustat have minimal cardiovascular side-effects compared with ESA injections. The oral administration of HIF-PH drugs is optimal for patients who are not undergoing hemodialysis. These factors are increasing the preference for these drugs, which will contribute to the growth of the global chronic renal failure therapeutics market. As a result of these factors, the market will register a CAGR of almost 5% during 2019-2023.
Top Chronic Renal Failure Therapeutics Companies Covered in this Market Research Report
The global chronic renal failure therapeutics market is fragmented. The chronic renal failure therapeutics market report provides an analysis of the market’s competitive landscape and offers information on the products offered by various companies. This will help clients in improving their market positions. It also provides a detailed analysis of the upcoming chronic renal disease, therapeutics market trends, and challenges that will influence market growth. The research will help companies in creating effective strategies to leverage the upcoming market growth opportunities.
The report offers a detailed analysis of many leading chronic renal failure therapeutics companies, including:
- Amgen Inc.
- AstraZeneca Plc
- Bayer AG
- F. Hoffmann-La Roche Ltd.
- Pfizer Inc.
Chronic Renal Failure Therapeutics Market Segmentation Based on Product
- Antihypertensive therapeutics
- Antianemia therapeutics
- Others
Antihypertensive therapeutics held the largest market share in 2018 and will maintain its leading position until 2023. Hypertension and diabetes account for 72% of the causes of chronic renal failure. Therefore, most of the current treatments, such as ACE and ARB inhibitors, calcium channel blockers, and diuretics, for chronic renal failure are targeted to control hypertension and blood sugar levels. These drugs are cost-effective and have been included in health insurance schemes. As a result, the use of these drugs will remain prevalent over the forecast period.
Chronic Renal Failure Therapeutics Market Segmentation Based on Geographic Region
- Asia
- Europe
- North America
- ROW
North America was the largest market shareholder in 2018. The growing prevalence of chronic renal failure, among the rising geriatric population, especially in the US and Canada, has been contributing to the growth of the market in the region. This coupled with the availability of reimbursement schemes, and new drug approvals will enable the market to retain its leading position in 2023.
Key Highlights of the Global Chronic Renal Failure Therapeutics Market Forecast Report for the Period 2019-2023
- CAGR of the market during the forecast period 2019-2023
- Detailed information on factors that will accelerate the growth of the chronic renal failure therapeutics market during the next five years
- Precise estimation of the global chronic renal failure therapeutics market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the chronic renal failure therapeutics industry across Asia, Europe, North America, and ROW
- A thorough analysis of the market’s competitive landscape and detailed information on several vendors
- Comprehensive details of factors that will challenge the growth of chronic renal failure therapeutics companies
We can help! Our analysts can customize the chronic renal failure therapeutics market research report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
- 2.1 Preface
- 2.2 Preface
- 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
- Market segmentation by product
- Comparison by product
- Antihypertensive therapeutics - Market size and forecast 2018-2023
- Antianemia therapeutics - Market size and forecast 2018-2023
- Others - Market size and forecast 2018-2023
- Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- ROW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 11: MARKET TRENDS
- Development of novel hypoxia-inducible factor prolyl hydroxylase
(HIF-PH) inhibitors
- Exploring research toward precision medicine
- Strategic alliances
PART 12: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 13: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Amgen Inc.
- AstraZeneca Plc
- Bayer AG
- F. Hoffmann-La Roche Ltd.
- Pfizer Inc.
PART 14: APPENDIX
- Research methodology
- List of abbreviations
- Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases

DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts

REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
Certified ISO 9001 : 2015

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
2500 USD
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
- Our analysts will work directly with you and understand your needs
- Get data on specified regions or segments, competitor and Vendors
- Data will be formatted and presented as per your requirements
- We offer $1000 worth of FREE customization at the time of purchase
Let us help you make report more suited to your requirements.
- Get a competitive breakdown as per your niche industry
- Customize the data with various metrics that meet your business prerequisite
- Understand Revenue Sources, Customers and many more
- Details on Market Share
- These customizations are done in a short amount of time by our analysts and industry experts
